321 related articles for article (PubMed ID: 17899018)
1. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers.
Zacny JP; Lichtor SA
Psychopharmacology (Berl); 2008 Jan; 196(1):105-16. PubMed ID: 17899018
[TBL] [Abstract][Full Text] [Related]
2. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
Zacny JP; Gutierrez S
Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers.
Zacny JP; Gutierrez S
Psychopharmacology (Berl); 2003 Nov; 170(3):242-254. PubMed ID: 12955305
[TBL] [Abstract][Full Text] [Related]
4. Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers.
Zacny JP; Gutierrez S
Psychopharmacology (Berl); 2011 Dec; 218(3):471-81. PubMed ID: 21603891
[TBL] [Abstract][Full Text] [Related]
5. Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
Stoops WW; Hatton KW; Lofwall MR; Nuzzo PA; Walsh SL
Psychopharmacology (Berl); 2010 Oct; 212(2):193-203. PubMed ID: 20665209
[TBL] [Abstract][Full Text] [Related]
6. The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.
Walsh SL; Nuzzo PA; Lofwall MR; Holtman JR
Drug Alcohol Depend; 2008 Dec; 98(3):191-202. PubMed ID: 18606504
[TBL] [Abstract][Full Text] [Related]
7. Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers.
Hill JL; Zacny JP
Psychopharmacology (Berl); 2000 Sep; 152(1):31-9. PubMed ID: 11041313
[TBL] [Abstract][Full Text] [Related]
8. Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers.
Zacny JP; Paice JA; Coalson DW
Pharmacol Biochem Behav; 2012 Jan; 100(3):560-5. PubMed ID: 22085697
[TBL] [Abstract][Full Text] [Related]
9. Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.
Walsh SL; Heilig M; Nuzzo PA; Henderson P; Lofwall MR
Addict Biol; 2013 Mar; 18(2):332-43. PubMed ID: 22260216
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.
Babalonis S; Lofwall MR; Nuzzo PA; Walsh SL
Addict Biol; 2016 Jan; 21(1):146-58. PubMed ID: 25130052
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers.
Zacny JP
Psychopharmacology (Berl); 2003 Jan; 165(2):146-56. PubMed ID: 12404072
[TBL] [Abstract][Full Text] [Related]
12. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
Cooper ZD; Bedi G; Ramesh D; Balter R; Comer SD; Haney M
Neuropsychopharmacology; 2018 Sep; 43(10):2046-2055. PubMed ID: 29463913
[TBL] [Abstract][Full Text] [Related]
13. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers.
Zacny JP; Conley K; Marks S
J Pharmacol Exp Ther; 1997 Mar; 280(3):1159-69. PubMed ID: 9067299
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.
Comer SD; Metz VE; Cooper ZD; Kowalczyk WJ; Jones JD; Sullivan MA; Manubay JM; Vosburg SK; Smith ME; Peyser D; Saccone PA
Behav Pharmacol; 2013 Sep; 24(5-6):504-16. PubMed ID: 23839029
[TBL] [Abstract][Full Text] [Related]
15. Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.
Zacny JP; Paice JA; Coalson DW
Drug Alcohol Depend; 2012 Aug; 124(3):274-82. PubMed ID: 22365897
[TBL] [Abstract][Full Text] [Related]
16. Abuse liability of oxycodone as a function of pain and drug use history.
Comer SD; Sullivan MA; Vosburg SK; Kowalczyk WJ; Houser J
Drug Alcohol Depend; 2010 Jun; 109(1-3):130-8. PubMed ID: 20079977
[TBL] [Abstract][Full Text] [Related]
17. Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids.
Kamboj SK; Conroy L; Tookman A; Carroll E; Jones L; Curran HV
Eur J Pain; 2014 Nov; 18(10):1376-84. PubMed ID: 24700581
[TBL] [Abstract][Full Text] [Related]
18. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
Zacny JP; Gutierrez S
Pain Med; 2008; 9(4):433-43. PubMed ID: 18489634
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study.
Staahl C; Dimcevski G; Andersen SD; Thorsgaard N; Christrup LL; Arendt-Nielsen L; Drewes AM
Scand J Gastroenterol; 2007 Mar; 42(3):383-90. PubMed ID: 17354119
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
